BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Novalyst Discovery and AliX Agree to Merge to Launch NovAliX


9/30/2008 10:15:56 AM

Integrating Structural Biology and Medicinal Chemistry

STRASBOURG, France--(BUSINESS WIRE)--Following long-standing cooperation, Novalyst Discovery, a chemistry services company, and AliX, a structural biology company, have agreed to merge to create a leading CRO. Together they have launched NovAliX, a multidisciplinary company providing flexible outsourcing solutions for drug discovery and development.

The combined company will represent a major provider able to deliver comprehensive services from gene to preclinical drug candidates and especially offering alternative fragment-based drug discovery approaches.

“There was a natural synergy between the two companies whose expertise in chemistry and structural biology brings a valuable set of skills for our drug discovery program”, claimed Stephan Jenn, President of both companies. “In the past, opportunities for joint programs have shown us that we were able to integrate our highly complementary expertise to conduct projects successfully.”

Since the beginning of 2008, both companies have been combining operations to facilitate the organizational process. “Our priority is to ensure that our clients receive even greater support as we go forward as one company.” In a competitive and demanding environment the combined company NovAliX will be a larger, stronger and more integrated organization offering clients access to a wider range of capabilities all the more since the integrated platform of comprehensive biological and chemical services is advantageously complemented by a high-value added screening technology. Indeed NovAliX has developed a unique and innovative platform using non-covalent mass spectrometry for compound screening and binding characterization. This mass spectrometry technology has emerged as an alternative and efficient technique for delivering high-content information on compound-protein interactions. Using this sensitive technique known as FAMASS™ (Fragments Analysis by MAss Spectrometry) in combination with its in-house fragment library, NovAliX proposes fragment-based drug discovery programs, a cost-effective approach for fast lead generation.

Information about integrated drug discovery research services can be found at novalix-pharma.com

About NovAliX

NovAliX is a contract research organization. Through a set of capabilities including protein delivery, X-ray protein structure determination, custom synthesis, chemistry R&D, medicinal chemistry and molecular modeling, NovAliX offers comprehensive services in research and development of small molecules. NovAliX, a team of 60 scientists, is located in state-of-the-art laboratory facilities (1600 m2) in the Strasbourg-Illkirch science cluster.

www.novalix-pharma.com

Contacts

NovAliX Anne Briot-Dietsch, PhD BioParc, Boulevard Sebastien Brant F-67400 Illkirch France info@novalix-pharma.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES